Prof. Dr. Sandro Gelsomino

Prof. Sandro Gelsomino studied medicine in Bologna. He was trained as a heart surgeon at the University Hospital S. Orsola Malpighi in Bologna and qualified in 1995. He was a fellow at the Bologna University from 1990 to 1995. He was a resident cardiac surgeon at Pinna Pintor Clinic and a staff member at Brescia Hospital from 1995 to 1997. From 1998 to 2003 he was a cardiac surgeon staff member at S. Maria della Misericordia Hospital, Udine, Italy, and a member of the stentless valve program. From 2003 to 2007, he was a staff surgeon at Careggi Hospital in Florence, Italy and he carried out a program on ischemic mitral regurgitation. From 2006 to 2008, he was the director (head) of the Experimental Surgery Unit, at Careggi Hospital Florence. In 2009, he obtained his Ph.D. on this subject at the Faculty of Medicine and Life Sciences at Maastricht University. In 2014, he was appointed as an associate professor, and in 2018 he became professor of heart surgery. One of the main topics of his research is atrial fibrillation (AF). He is developing a new true hybrid true bipolar tool (CORDIA) for the ablation of atrial fibrillation which has been patented with the support of Maastricht University. In addition, he is developing, in collaboration with MERLIN, a patch for several applications in the field of cardiovascular medicine, apart from AF. At the University of Florence, he is involved in the program for new anti-oxidants for the treatment of AF.